Bullet points of Drugmakers to stop making controversial fentanyl lollipops, FDA says
Bullet points of Drugmakers to stop making controversial fentanyl lollipops, FDA says
- Drugmakers have decided to stop selling a type of fentanyl painkiller
- The decision follows decades of investigations and lawsuits against the drugmakers
- The FDA stated that there are fewer than 150 patients receiving treatment with TIRF medicines
- Patients who are currently on one of these medicines may continue treatment while the supply is available
- Drugmakers have decided to stop selling a type of fentanyl painkiller
- The decision follows decades of investigations and lawsuits against the drugmakers
- The FDA stated that there are fewer than 150 patients receiving treatment with TIRF medicines
- Patients who are currently on one of these medicines may continue treatment while the supply is available